▶
PAVE delivers real-world evidence that new tools can accelerate elimination of relapsing malaria
The landscape for the treatment of relapsing malaria has transformed considerably in recent years, due in part to the achievements of the Partnership for Vivax Elimination (PAVE).
Led by MMV and PATH, PAVE has helped bring new tools for relapsing #malaria into routine use, from point-of-care testing to treatments in both paediatric and adult formulations.